The National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), intends to negotiate with the University of Medicine and Dentistry of New Jersey, for a modification of its contract No. N01-AI-95356, which was awarded under full and open competition. This contract provides a comprehensive quality assessment program to NIAID-supported laboratories and collaborating investigators that perform immunological assays on samples from subjects enrolled in multi-site clinical and epidemiological HIV investigations. This program also facilitates the development, standardization and implementation of new immunological assays for use in multi-site HIV therapeutic, vaccine, prevention and epidemiological investigations. These services must urgently be extended to support research on diagnosis, prevention and treatment of infections caused by Class A, B, and C agents of bioterrorism as defined by the CDC -- www.bt.cdc.gov/agent/agentlist.asp. Services must also be expanded to include testing of samples from patients enrolled in treatment and vaccination studies. Authority: 41 USC 253(c)(1), as set forth in FAR 6.302-1. Inherent duplication of cost to the Government and unacceptable delays in completing the project make competition unfeasible for this requirement. See Numbered Note 22. No collect calls will be accepted.

Bid Protests Not Available